GoodRx Holdings (GDRX) Receivables - Other (2025 - 2026)

GoodRx Holdings (GDRX) posted Receivables - Other of $11.9 million for Q1 2026, little changed sequentially from $11.9 million in Q4 2025.

GoodRx Holdings (GDRX) Receivables - Other (2025 - 2026) Analysis & Trends

GoodRx Holdings has reported Receivables - Other for 2 years, with the latest figure at $11.9 million in Q1 2026.

Quarterly Receivables - Other changed N/A year-over-year to $11.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.9 million (changed N/A YoY) and the FY2025 annual result came in at $11.9 million, changed N/A from the prior year.
Receivables - Other was little changed at $11.9 million in Q1 2026 per GDRX's latest filing, from $11.9 million in the prior quarter.
Over five years, Receivables - Other peaked at $11.9 million in Q4 2025 and troughed at $11.9 million in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Veeva Systems	39.72 Bn	32.40 Bn	662.02 Mn
2	BrightSpring Health Services	12.19 Bn	11.64 Bn	492.75 Mn
3	Healthequity	8.79 Bn	8.52 Bn	256.31 Mn
4	10x Genomics	7.31 Bn	6.76 Bn	112.50 Mn
5	Hinge Health	7.10 Bn	6.71 Bn	183.95 Mn
6	MiniMed	5.66 Bn	5.36 Bn	480.00 Mn
7	Waystar Holding	4.76 Bn	4.56 Bn	221.99 Mn
8	Doximity	4.46 Bn	3.77 Bn	132.93 Mn
9	Heartflow	3.66 Bn	3.28 Bn	53.19 Mn
10	GoodRx Holdings	1.27 Bn	972.56 Mn	179.41 Mn

Download Data